Benjamin Pearce
Vascular Surgery · Birmingham, ALNPI 1932308699
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $24,028 of the $37,013 with a category attached, or 64.9%. 20 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 54.5% of the total. Among vascular surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $163.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$20K
- Bolton Medical Inc$10K
- Cook Medical LLC$2K
- Terumo Medical Corporation$1K
- Medtronic$996
- Penumbra, Inc.$771
- plus $2K from 14 others
Across 31 payments — averaging $5848.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$77K
- Medtronic$71K
- Bolton Medical Inc$33K
What the payments were for
- Consulting fees$10,26028%
- Travel & lodging$2,7257%
- Food & beverage$24,02865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 109 | $20,160 |
| Bolton Medical Inc | 25 | $10,460 |
| Cook Medical LLC | 22 | $1,558 |
| Terumo Medical Corporation | 14 | $1,089 |
| Medtronic(2 entities) | 15 | $996 |
| Penumbra, Inc. | 7 | $771 |
| Silk Road Medical, Inc. | 8 | $456 |
| Mentor Worldwide LLC | 12 | $366 |
| Integra Lifesciences Corporation | 2 | $307 |
| Atrium Medical Corporation | 1 | $208 |
| Abbott | 2 | $171 |
| Sientra, Inc. | 1 | $122 |
| Shape Memory Medical Inc. | 1 | $65 |
| Intuitive Surgical | 1 | $64 |
| Johnson & Johnson | 1 | $55 |
| AbbVie | 2 | $48 |
| Lemaitre Vascular, Inc. | 1 | $45 |
| Boston Scientific | 1 | $35 |
| Apyx Medical Corporation | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE VIABAHN VBX Balloon Expandable Endo$11,549
- Relay Plus$9,348
- GORE VIABAHN Endoprosthesis$7,908
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$2,850
- GORE VIABAHN Endoprosthesis with Heparin$1,871
- GORE EXCLUDER AAA Endoprosthesis$1,853
- EXCLUDER AAA Endoprosthesis$1,838
- GORE EXCLUDER Iliac Branch Endoprosthesis$1,710
- GORE-TEX Vascular Graft$1,710
- INTEGRA$615
- Penumbra System$527
- Azur CX Detachable$508
- Conformable TAG Thoracic Endoprosthesis$437
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$437
- ENDURANT IIS$421
- AZUR$396
- Relay Grafts$374
- OMNIGRAFT$307
- SURGIMEND$307
- INTEGRA DERMAL REGENERATION TEMPLATE$307
How this compares
$37,013 in reported general payments places this provider in the 90th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 62 | $53,128 |
| EliquisApixaban | 54 | $47,181 |
| ClopidogrelClopidogrel Bisulfate | 127 | $2,213 |
| Rosuvastatin Calcium | 67 | $1,975 |
| Gabapentin | 59 | $835 |
| Atorvastatin Calcium | 45 | $766 |
| Cilostazol | 29 | $757 |
| Oxycodone Hcl | 37 | $182 |
| Simvastatin | 16 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $55 | $53,12862 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Birmingham
- Albert PacificoBirmingham$5.1M
- William HolmanBirmingham$25K
- Stephen HeinzmanBirmingham$18K
- Jarrad RowseBirmingham$10K
- Graeme McFarlandBirmingham$10K
- Vernon HorstBirmingham$9K
- James KirklinBirmingham$6K
- Danielle SutzkoBirmingham$5K
- Mark PattersonBirmingham$5K
- Michael GleasonBirmingham$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.